ARCHIVES

Science Policy: All’s Well In Access to Trials, GAO Study Finds; NIH Disagrees

This article is from The Cancer Letter archive.

Vol. 25 No. 42 | November 5, 1999

Download PDF Visit The Full Archive

Related Articles

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

DeVita Emphasizes NCI Prevention In Statement To Senate Committee

February 15, 1980

In Brief: Senate Markup Of Cancer Act Renewal Bill Delayed Again; New Money Levels Considered Still Too Low

November 9, 1979

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

Consensus Conference On Receptors Planned

June 22, 1979

ORI Finds Misconduct By Harvard Physician On Cancer Protocol; Two Other Cases

June 9, 1995